News

Podcast

March 24, 2019

Podcast: This Week in Managed Care—Cardiovascular Prevention Guidelines and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care^® (AJMC^®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included the 2020 budget plan proposing a mix of healthcare spending cuts and increases; the FDA approving the first immunotherapy regimen for breast cancer; and researchers uncovering how sodium glucose co-transporter-2 inhibitors work.

You may need to log in to the website to access this podcast.

Listen above or through one of these podcast services:

Cardiovascular Prevention Guidelines Call for Less Aspirin, More SGLT2s, GLP-1s for Type 2 Diabetes

Giant Study Suggests Apple Watch Accurately Catches Atrial Fibrillation

DECLARE: Dapagliflozin Offers Benefits for Diabetes Patients With Heart Failure

Amarin's High-Dose Fish Oil Pill Cuts Total CV Event Risk 30% in Study

American College of Cardiology 2019

FDA Expands Patient Inclusion Criteria for Cancer Clinical Trials

Dr Janice Mehnert Discusses Including Patients With Comorbidities in Cancer Clinical Trials

Reducing Low-Value Care May Mean Tough Conversations With Stakeholders

V-BID Summit 2019

Participation in Community Groups Found to Increase Awareness of PrEP

Newsletter Signup

ACCC Annual Meeting & Cancer Center Business Summit

National Comprehensive Cancer Network Annual Conference 2019

Read more about the stories in this podcast:

Related Videos

1 expert in this video

1 expert in this video

Benjamin Chen, MD, PhD

Benjamin Chen, MD, PhD

Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center

Lynae Darbes, PhD

Bridgette Picou, LVN, ACLPN, The Well Project

Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth

Lynae Darbes, PhD

Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center

Related Content

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com

April 29th 2025

New Developments Warrant Rethinking HCC Transplant Criteria

Jared Kaltwasser

Downstaging and bridging strategies are changing how hepatocellular carcinoma (HCC) is treated.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Women with fatigue | Image credit: Adobe Stock

April 29th 2025

Fatigue, Depression Hit Harder on Women Cancer Survivors, Data Show

Prior studies have shown that women may absorb cancer therapies differently than men, but this study focused on the fallout on patients' physical activity and quality of life.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

NSCLC | Image: Lung Cancer Foundation of America

April 28th 2025

Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC

Mary Caffrey Brooke McCormick

Results could give patients with HER2-mutated non–small cell lung cancer (NSCLC) an oral therapy option.

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com

April 23rd 2025

Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

AJMC Contributor

Even with prevention measures and timely, aggressive intervention, tumor lysis syndrome (TLS) remains life-threatening, as a case study in small cell lung cancer (SCLC) illustrates.

Related Content

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com

April 29th 2025

New Developments Warrant Rethinking HCC Transplant Criteria

Jared Kaltwasser

Downstaging and bridging strategies are changing how hepatocellular carcinoma (HCC) is treated.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Women with fatigue | Image credit: Adobe Stock

April 29th 2025

Fatigue, Depression Hit Harder on Women Cancer Survivors, Data Show

Prior studies have shown that women may absorb cancer therapies differently than men, but this study focused on the fallout on patients' physical activity and quality of life.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

NSCLC | Image: Lung Cancer Foundation of America

April 28th 2025

Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC

Mary Caffrey Brooke McCormick

Results could give patients with HER2-mutated non–small cell lung cancer (NSCLC) an oral therapy option.

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com

April 23rd 2025

Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

AJMC Contributor

Even with prevention measures and timely, aggressive intervention, tumor lysis syndrome (TLS) remains life-threatening, as a case study in small cell lung cancer (SCLC) illustrates.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions